These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2149873)

  • 1. Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside.
    Vaccari A; Stefanini E; de Montis G; Rossetti ZL
    Neuropharmacology; 1990 Dec; 29(12):1161-9. PubMed ID: 2149873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal hypothyroidism induces striatal dopaminergic dysfunction.
    Vaccari A; Rossetti ZL; de Montis G; Stefanini E; Martino E; Gessa GL
    Neuroscience; 1990; 35(3):699-706. PubMed ID: 2199846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Hadjiconstantinou M; Neff NH
    J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
    Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
    Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
    Pope-Coleman A; Tinker JP; Schneider JS
    Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 ganglioside treatment promotes recovery of electrically-stimulated [3H]dopamine release in striatal slices from rats lesioned with kainic acid.
    Raiteri M; Bonanno G; Pende M; Versace P
    Neurosci Lett; 1992 Feb; 136(1):127-30. PubMed ID: 1321965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion.
    Raiteri M; Versace P; Marchi M
    Eur J Pharmacol; 1985 Dec; 118(3):347-50. PubMed ID: 4085560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS
    J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Schneider JS
    Neuropharmacology; 1992 Feb; 31(2):185-92. PubMed ID: 1553028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
    Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
    Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.
    Toffano G; Savoini G; Moroni F; Lombardi G; Calza L; Agnati LF
    Brain Res; 1983 Feb; 261(1):163-6. PubMed ID: 6132660
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside.
    Hadjiconstantinou M; Yates AJ; Neff NH
    J Neurochem; 1990 Sep; 55(3):864-9. PubMed ID: 1696622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
    Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover.
    Vital MA; Flório JC; Frussa-Filho R; De Lucia R; Tufik S; Palermo-Neto J
    Life Sci; 1998; 62(13):1161-9. PubMed ID: 9519797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
    Rothblat DS; Schneider JS
    Ann N Y Acad Sci; 1998 Jun; 845():274-7. PubMed ID: 9668361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion.
    Schneider JS; Distefano L
    Neuropharmacology; 1995 May; 34(5):489-93. PubMed ID: 7566482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.
    Schneider JS; DiStefano L
    Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.